2 months BioMarin Q3 Earnings & Revenues Beat Estimates, ’24 Guidance Raised Zacks
BMRN reports better-than-expected third-quarter results, beating both earnings and sales estimates. Management raises 2024 guidance.
Biomarin Pharma (BMRN) · Earnings
X